A close icon

Interested in becoming an advocate?

Oops! Something went wrong while submitting the form.
Back to main page


Once a day subcutaneous injection

Ozempic (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of type 2 diabetes.

Victoza (generic name: Liraglutide) is a GLP-1 agonist FDA approved for weight management.

How does



  • act on brain signaling to reduce food intake
  • helps control blood sugar levels by increasing the release of insulin from the pancreas
  • slows down food leaving your stomach, thus, keeping you fuller for longer 

Common side effects of


  • nausea
  • vomiting
  • decreased appetite 
  • diarrhea
  • stomach (abdominal) pain
  • constipation
  • indigestion

Expected Results: 

  • Helps control blood sugar levels
  • Decreased HgbA1C
  • Patients lost on average 5% of initial body weight

Do not take


if you:

  • have or any of your family members have ever had medullary thyroid carcinoma (MTC) or if you have MEN2
  • are pregnant, planning to become pregnant or breastfeeding
  • have or have had history of pancreatitis 
  • history of chronic malabsorption
  • history of gallbladder disease 
  • have a history of gastroparesis or IBD
  • are allergic to liraglutide or any of the ingredients* in Victoza

*non-medicinal ingredients in Victoza: Disodium phosphate dihydrate, 1.42 mg; propylene glycol, 14 mg; phenol, 5.5 mg; and water for injection.

Disclaimer: Please note that the following list may not encompass all potential side effects or drug interactions. To determine if any drug or supplement you are currently taking could interact with a medication, we strongly advise consulting your healthcare provider or pharmacist. Seek medical advice immediately if you experience any adverse reaction.